Thyroid Antibodies Test: TPO, Thyroglobulin, and What High Levels Mean

Thyroid Antibody Types and What They Indicate

Key distinction: TPO-Ab and Tg-Ab are associated with thyroid destruction (leading to hypothyroidism), while TSI and TRAb stimulate the thyroid (leading to hyperthyroidism in Graves' disease). Testing the right antibody for the right clinical picture is essential — they point in opposite directions.

TPO Antibody Normal Range and Interpretation

Featured answer: TPO antibody normal range is below 9 IU/mL (Quest Diagnostics) or below 34 IU/mL (LabCorp). Cleveland Clinic uses a cutoff of less than 5.6 IU/mL. Levels above the lab's reference range indicate the immune system is producing antibodies against thyroid tissue. Because reference ranges vary between laboratories, always compare your result against the range printed on your specific report.

Important nuance: Antibody levels can fluctuate and do not directly predict symptom severity. A declining trend (e.g., from 600 to 180 IU/mL over 12 months) is a meaningful positive signal — direction of change matters as much as the absolute value.

TPO vs. Thyroglobulin Antibody: Key Differences

Both antibodies can be elevated in Hashimoto's thyroiditis, but they have important clinical differences:

• Frequency: In autoimmune hypothyroidism, 50–90% of patients have elevated TPO-Ab, while only 30–50% have elevated Tg-Ab. TPO-Ab is the primary diagnostic marker for Hashimoto's.
• Specificity: TPO-Ab is more specific for autoimmune thyroid disease. Tg-Ab alone, without elevated TPO-Ab, is a less common and somewhat less specific pattern.
• Cancer monitoring: After thyroid cancer surgery or radioactive iodine treatment, Tg-Ab is tracked because it can interfere with the thyroglobulin tumor marker test. Rising Tg-Ab post-treatment may indicate cancer recurrence even when thyroglobulin itself is undetectable.
• Testing both: Running both antibodies provides a fuller picture of the autoimmune landscape. Some patients have only one elevated; others have both. Either is sufficient to suggest autoimmune thyroid disease when clinical context supports it.

If only Tg-Ab is elevated with normal TPO-Ab and normal TSH, discuss with your doctor whether repeat testing or thyroid ultrasound is warranted, as isolated Tg-Ab elevation can occasionally occur in healthy individuals.

High TPO Antibodies with Normal TSH: What It Means

This is one of the most common sources of confusion in thyroid health. Having elevated TPO antibodies with a normal TSH does not mean there is no problem — it means you have early or subclinical autoimmune thyroid disease. The immune system is actively attacking thyroid tissue, but the thyroid has enough reserve to maintain normal hormone output for now.

This pattern is sometimes called euthyroid Hashimoto's (euthyroid = normal thyroid function). Key facts:

• TPO antibodies typically become elevated 3–10 years before TSH rises above the normal range, and can be elevated for 10–20 years before overt hypothyroidism develops.
• Approximately 20–30% of people with positive TPO antibodies and normal TSH will develop overt hypothyroidism within five years.
• Annual risk of progression is roughly 2–5% per year, rising to 4.3% per year if TSH is at the upper end of normal (above 2.5 mIU/L).
• About 10–15% of healthy adults have mildly elevated TPO antibodies without ever developing significant thyroid disease — context and trends matter.

If you have high TPO antibodies and normal TSH, the right response is structured monitoring (every 6–12 months), not dismissal. See also: hormone imbalance and how to balance hormones naturally.

Hashimoto's Thyroiditis: The Antibody Connection

Hashimoto's thyroiditis is an autoimmune disease in which the immune system progressively destroys thyroid tissue. It is the most common cause of hypothyroidism in iodine-sufficient countries. The disease unfolds in stages:

1. Stage 1 — Immune activation: TPO antibodies become detectable. TSH and thyroid hormones remain normal. This can persist for years to decades.
2. Stage 2 — Early dysfunction: TSH begins rising (often to 2.5–5.0 mIU/L) as the thyroid works harder to compensate for damage. Free T4 is still normal. Symptoms like fatigue, brain fog, and hair loss may appear.
3. Stage 3 — Subclinical hypothyroidism: TSH rises above 4.5–5.0 mIU/L; free T4 remains within the lower end of normal. Treatment is debated — most guidelines recommend it if TSH exceeds 10 or if the patient is symptomatic or pregnant.
4. Stage 4 — Overt hypothyroidism: TSH is elevated and free T4 is below normal. Levothyroxine replacement is standard of care.

Elevated TPO antibodies in a patient with subclinical or overt hypothyroidism confirm the autoimmune etiology (Hashimoto's) rather than other causes of hypothyroid patterns. This distinction matters because it predicts faster progression, guides monitoring frequency, and informs treatment decisions during pregnancy. See the full hypothyroidism guide.

Graves' Disease Antibodies: TSI and TRAb

Graves' disease is the most common cause of hyperthyroidism, accounting for approximately 83% of cases. Unlike Hashimoto's — where antibodies destroy the thyroid — Graves' antibodies stimulate it into overdrive. Two tests identify this:

• TSI (thyroid-stimulating immunoglobulin): Binds to and activates the TSH receptor, mimicking TSH and causing the thyroid to produce excess hormones continuously. Present in approximately 95% of Graves' disease patients. A TSI level above 0.55 IU/mL is considered positive.
• TRAb (TSH receptor antibody): A broader test that detects all TSH receptor antibodies — both stimulating and blocking types. Positive in about 95% of Graves' patients. TRAb levels track treatment response — persistently elevated levels after 12–18 months of antithyroid medication predict relapse after discontinuation.

Graves' disease can also cause elevated TPO antibodies (in 50–75% of cases), which is why the diagnosis of Graves' requires TSI or TRAb testing — not just an elevated TPO. In pregnancy, Graves' antibodies cross the placenta and can cause fetal or neonatal hyperthyroidism, making TRAb monitoring during pregnancy clinically critical.

What to Do If Your Thyroid Antibodies Are Elevated

Step 1: Get a complete picture. Elevated antibodies alone do not tell the whole story. Request a full thyroid panel (TSH, free T4, free T3) if not already done. If TSH is normal, the emphasis shifts to monitoring and lifestyle. If TSH is elevated, treatment decisions follow standard hypothyroidism guidelines.

Step 2: Consider thyroid ultrasound. Ultrasound can detect structural changes (reduced echogenicity, nodules, characteristic Hashimoto's texture) even when labs are borderline. This is especially useful when antibodies are elevated but TSH is still normal.

Step 3: Address modifiable contributors. Evidence supports several interventions that can reduce TPO antibody levels over time:

• Selenium supplementation: 200 mcg/day of selenomethionine is the best-studied intervention. A 2024 systematic review and meta-analysis of 21 randomized trials (1,610 participants) found selenium supplementation significantly reduced TPO-Ab levels at 3 and 6 months in Hashimoto's patients not on thyroid hormone therapy. Effect size was moderate; evidence certainty was moderate.
• Vitamin D optimization: Vitamin D deficiency is prevalent in autoimmune thyroid disease. Targeting 25(OH)D levels of 50–80 ng/mL is reasonable, though direct antibody-lowering evidence for vitamin D alone is weaker than for selenium.
• Gluten elimination: In patients with co-existing celiac disease or non-celiac gluten sensitivity, strict gluten elimination over 3–6 months may reduce TPO antibody levels. Testing for celiac (tissue transglutaminase IgA) is warranted in patients with Hashimoto's, as the two conditions co-occur at higher than expected rates.
• Iodine moderation: Very high iodine intake can worsen autoimmune thyroid disease. Current guidelines recommend 150–250 mcg/day — enough to support hormone synthesis without exacerbating inflammation.

Step 4: Track trends, not just snapshots. Retest TPO antibodies every 6–12 months. A consistent downward trend is a meaningful sign that interventions are working — even if values remain elevated above normal.

Step 5: Pregnancy considerations. Women with elevated TPO antibodies who are pregnant or planning pregnancy need closer monitoring. Elevated TPO-Ab is associated with increased risk of miscarriage, preterm birth, and postpartum thyroiditis. Many specialists recommend maintaining TSH below 2.5 mIU/L throughout pregnancy in TPO-positive women, even if TSH would not otherwise trigger treatment. See also: understanding blood test results.